Structures by: Cagide F.
Total: 38
(Z)-3-[(Phenylamino)methylene]chroman-2,4-dione
C16H11NO3
Chemical communications (Cambridge, England) (2015) 51, 14 2832
a=16.539(3)Å b=6.2596(12)Å c=11.472(2)Å
α=90.00° β=90.00° γ=90.00°
C16H11NO3
C16H11NO3
Chemical communications (Cambridge, England) (2015) 51, 14 2832
a=6.6795(2)Å b=7.3003(3)Å c=24.6020(17)Å
α=90.00° β=94.306(7)° γ=90.00°
4-oxo-N-(2-bromophenyl)-4H-chromene-2-carboxamide
C16H10BrNO3
Acta Crystallographica Section B (2013) 69, 3 294-309
a=5.466(3)Å b=17.381(10)Å c=13.948(8)Å
α=90.00° β=92.079(11)° γ=90.00°
4-oxo-N-(3-bromophenyl)-4H-chromene-2-carboxamide
C16H10BrNO3
Acta Crystallographica Section B (2013) 69, 3 294-309
a=23.047(8)Å b=4.8246(15)Å c=12.075(4)Å
α=90.00° β=90.00° γ=90.00°
4-oxo-N-(2-nitrophenyl)-4H-chromene-2-carboxamide
C16H10N2O5
Acta Crystallographica Section B (2013) 69, 3 294-309
a=12.3425(10)Å b=5.885(4)Å c=18.316(15)Å
α=90.00° β=99.543(13)° γ=90.00°
C16H10BrNO3
C16H10BrNO3
Acta Crystallographica Section B (2013) 69, 3 294-309
a=5.722(5)Å b=7.968(7)Å c=14.558(13)Å
α=96.004(13)° β=99.996(15)° γ=92.558(15)°
4-oxo-N-(3-methoxyphenyl)-4H-chromene-2-carboxamide
C17H13NO4
Acta Crystallographica Section B (2013) 69, 3 294-309
a=12.82(3)Å b=26.29(6)Å c=3.802(9)Å
α=90.00° β=90.00° γ=90.00°
C18H15NO3
C18H15NO3
Acta Crystallographica Section B (2013) 69, 3 294-309
a=21.094(9)Å b=16.297(7)Å c=8.402(3)Å
α=90.00° β=90.00° γ=90.00°
N-methyl-4-oxo-N-phenyl-4H-chromene-2-carboxamide
C17H13NO3
Acta Crystallographica Section B (2013) 69, 3 294-309
a=7.4724(5)Å b=9.3647(4)Å c=10.5398(5)Å
α=88.283(13)° β=71.1730(10)° γ=72.4200(10)°
N-(4-methylphenyl)-7-Methoxy-4-oxo-4H-chromone-2-carboxamide
C18H15NO4
Acta Crystallographica Section B (2013) 69, 3 294-309
a=14.327(4)Å b=8.468(2)Å c=12.708(3)Å
α=90.00° β=110.514(3)° γ=90.00°
<i>N</i>-(3-Methoxyphenyl)-4-oxo-4<i>H</i>-chromene-3-carboxamide
C17H13NO4
Acta Crystallographica Section E (2015) 71, 5 547-554
a=9.6903(2)Å b=5.5303(4)Å c=24.9335(18)Å
α=90° β=99.162(5)° γ=90°
<i>N</i>-(2-Nitrophenyl)-4-oxo-4<i>H</i>-chromene-3-carboxamide
C16H10N2O5
Acta Crystallographica Section E (2015) 71, 5 547-554
a=14.104(9)Å b=12.692(8)Å c=7.340(5)Å
α=90° β=100.065(13)° γ=90°
<i>N</i>-(4-Methylphenyl)-4-oxo-4<i>H</i>-chromene-3-carboxamide
C17H13NO3
Acta Crystallographica Section E (2015) 71, 5 547-554
a=6.6106(5)Å b=7.0143(5)Å c=15.3749(11)Å
α=91.444(6)° β=95.238(6)° γ=112.551(8)°
<i>N</i>-(3-Bromophenyl)-4-oxo-4<i>H</i>-chromene-3-carboxamide
C16H10BrNO3
Acta Crystallographica Section E (2015) 71, 5 547-554
a=6.74350(10)Å b=7.30120(10)Å c=28.0740(9)Å
α=85.309(4)° β=89.164(4)° γ=70.645(3)°
<i>N</i>-(4-Hydroxyphenyl)-4-oxo-4<i>H</i>-chromene-3-carboxamide
C16H11NO4
Acta Crystallographica Section E (2015) 71, 5 547-554
a=7.0756(5)Å b=12.5125(9)Å c=14.2944(10)Å
α=86.267(8)° β=83.839(8)° γ=84.588(8)°
<i>N</i>-(6-Hydroxyhexyl)-3,4,5-trimethoxybenzamide
C16H25NO5
Acta Crystallographica Section E (2016) 72, 5 675-682
a=22.3351(18)Å b=5.0467(4)Å c=14.2265(10)Å
α=90° β=99.956(7)° γ=90°
<i>N</i>-(6,6-Diethoxyhexyl)-3,4,5-trimethoxybenzamide
C20H33NO6
Acta Crystallographica Section E (2016) 72, 5 675-682
a=24.6345(18)Å b=8.4646(5)Å c=10.0598(7)Å
α=90° β=100.851(2)° γ=90°
<i>N</i>-(6-Anilinohexyl)-3,4,5-trimethoxybenzamide
C22H30N2O4
Acta Crystallographica Section E (2016) 72, 5 675-682
a=11.5626(8)Å b=19.5328(9)Å c=9.5488(7)Å
α=90° β=109.369(8)° γ=90°
<i>N</i>-(4-Fluorophenyl)-4-oxo-4<i>H</i>-chromene-3-carboxamide
C16H10FNO3
Acta Crystallographica Section E (2015) 71, 1 88-93
a=6.6213(5)Å b=7.0517(5)Å c=14.0864(10)Å
α=101.957(7)° β=90.047(6)° γ=106.657(7)°
<i>N</i>-(4-Bromophenyl)-4-oxo-4<i>H</i>-chromene-3-carboxamide
C16H10BrNO3
Acta Crystallographica Section E (2015) 71, 1 88-93
a=6.6505(5)Å b=9.3580(7)Å c=11.0060(8)Å
α=100.280(6)° β=90.461(6)° γ=100.884(6)°
<i>N</i>-(4-Chlorophenyl)-4-oxo-4<i>H</i>-chromene-3-carboxamide
C16H10ClNO3
Acta Crystallographica Section E (2015) 71, 1 88-93
a=6.6325(12)Å b=7.0577(12)Å c=14.671(3)Å
α=103.536(7)° β=89.714(6)° γ=105.589(7)°
<i>N</i>-(4-Iodophenyl)-4-oxo-4<i>H</i>-chromene-3-carboxamide
C16H10INO3
Acta Crystallographica Section E (2015) 71, 1 88-93
a=6.6750(5)Å b=9.4166(7)Å c=11.2673(8)Å
α=100.974(6)° β=90.769(6)° γ=100.062(6)°
<i>N</i>-(5-Methylthiazol-2-yl)-4-oxo-4<i>H</i>-chromene-3-carboxamide
C14H10N2O3S
Acta Crystallographica Section E (2017) 73, 8 1154-1161
a=4.8722(4)Å b=12.0436(10)Å c=21.9803(16)Å
α=90° β=96.353(8)° γ=90°
C14H10N2O3S
C14H10N2O3S
Acta Crystallographica Section E (2017) 73, 8 1154-1161
a=7.4646(5)Å b=30.626(2)Å c=11.0869(8)Å
α=90° β=93.232(2)° γ=90°
2-[(9-Acetyl-9<i>H</i>-purin-6-yl)sulfanyl]-1-(3-methoxyphenyl)ethan-1-one
C16H14N4O3S
Acta Crystallographica Section E (2016) 72, 3 307-313
a=7.6343(5)Å b=26.2356(18)Å c=8.1332(5)Å
α=90° β=112.725(2)° γ=90°
2-[(9-Acetyl-9<i>H</i>-purin-6-yl)sulfanyl]-1-(4-methoxyphenyl)ethan-1-one
C16H14N4O3S
Acta Crystallographica Section E (2016) 72, 3 307-313
a=5.9920(3)Å b=9.9795(5)Å c=24.9907(13)Å
α=90° β=95.977(5)° γ=90°
2-[(9-Acetyl-9<i>H</i>-purin-6-yl)sulfanyl]-1-(4-chlorophenyl)ethan-1-one
C15H11ClN4O2S
Acta Crystallographica Section E (2016) 72, 3 307-313
a=5.9900(4)Å b=9.9169(7)Å c=24.3238(17)Å
α=90° β=96.072(2)° γ=90°
1-(3-Methoxyphenyl)-2-[(9<i>H</i>-purin-6-yl)sulfanyl]ethan-1-one
C14H12N4O2S
Acta Crystallographica Section E (2016) 72, 3 307-313
a=7.6683(5)Å b=21.8004(15)Å c=8.4131(5)Å
α=90° β=107.507(2)° γ=90°
6-(2-Hydroxybenzoyl)-5<i>H</i>-thiazolo[3,2-<i>a</i>]pyrimidin-5-one
C13H8N2O3S
Acta Crystallographica Section E (2015) 71, 7 766-771
a=7.5563(5)Å b=15.3187(11)Å c=10.1229(7)Å
α=90° β=99.49(2)° γ=90°
6-(2-Hydroxybenzoyl)-2-methyl-5<i>H</i>-thiazolo[3,2-<i>a</i>]pyrimidin-5-one
C14H10N2O3S
Acta Crystallographica Section E (2015) 71, 7 766-771
a=3.931(2)Å b=10.459(6)Å c=14.657(8)Å
α=90° β=94.201(14)° γ=90°
<i>N</i>-Methyl-4-oxo-<i>N</i>-phenyl-4<i>H</i>-chromene-3-carboxamide
C17H13NO3
Acta crystallographica. Section E, Crystallographic communications (2015) 71, Pt 11 1270-1277
a=6.716(4)Å b=6.809(4)Å c=29.425(17)Å
α=90.00° β=94.784(7)° γ=90.00°
3-(Pyrrolidine-1-carbonyl)-4<i>H</i>-chromen-4-one
C14H13NO3
Acta crystallographica. Section E, Crystallographic communications (2015) 71, Pt 11 1270-1277
a=7.430(3)Å b=11.963(6)Å c=12.648(6)Å
α=90° β=90° γ=90°
2-(Pyrrolidine-1-carbonyl)-4<i>H</i>-chromen-4-one
C14H13NO3
Acta crystallographica. Section E, Crystallographic communications (2015) 71, Pt 11 1270-1277
a=15.337(6)Å b=21.940(8)Å c=6.808(3)Å
α=90° β=90° γ=90°
<i>N</i>-(2-Methoxyphenyl)-4-oxo-4<i>H</i>-chromone-3-carboxamide
C17H13NO4
Acta Crystallographica Section C (2013) 69, 8 927-933
a=8.9867(18)Å b=20.669(4)Å c=14.856(3)Å
α=90.00° β=93.545(4)° γ=90.00°
<i>N</i>-(2-Methoxyphenyl)-4-oxo-4<i>H</i>-chromone-3-carboxamide
C17H13NO4
Acta Crystallographica Section C (2013) 69, 8 927-933
a=14.614(13)Å b=23.95(2)Å c=8.125(7)Å
α=90.00° β=102.069(17)° γ=90.00°
4-oxo-N-(2-methoxyphenyl)-4H-chromene-2-carboxamide
C17H13NO4
Acta Crystallographica Section B (2013) 69, 3 294-309
a=4.7199(12)Å b=15.345(5)Å c=19.338(6)Å
α=90.00° β=90.00° γ=90.00°
<i>N</i>-(4-Methoxyphenyl)-4-oxo-4<i>H</i>-chromene-3-carboxamide
C17H13NO4
Acta Crystallographica Section E (2015) 71, 5 547-554
a=14.1629(10)Å b=6.772(5)Å c=15.1898(11)Å
α=90° β=116.607(11)° γ=90°
2-[(9-Acetyl-9<i>H</i>-purin-6-yl)sulfanyl]-1-(4-bromophenyl)ethan-1-one
C15H11BrN4O2S
Acta Crystallographica Section E (2016) 72, 3 307-313
a=6.0705(4)Å b=10.0668(7)Å c=24.3492(17)Å
α=90° β=96.580(2)° γ=90°